Pathology, TWINCREST team up for in-office pathology services

Article

TWINCREST, LLC has formed a joint venture with Pathology Solutions, LLC, to offer expanded in-office pathology services for specialty medical practices.

TWINCREST LLC has formed a joint venture with Pathology Solutions, LLC, to offer expanded in-office pathology services for specialty medical practices.

“With this joint venture, TWIN Solutions will be able to offer clients reference pathology testing services, technical/professional in-office pathology services, and true in-office pathology laboratory services,” said Pat Kalish, speaking for TWINCREST. “If [offices] want to have slides prepared for their local pathologist to read, we can do that for them. If they want to install their own pathology lab, we can do that for them as well. We will also be able to handle any specimens that cannot be processed in either scenario above as a reference laboratory.”

Pathology Solutions is an expanding specialty pathology reference laboratory providing in-office pathology technical and professional services to specialty urology, gastroenterology, and dermatology practices nationwide. TWINCREST is a leader in the field of in-office pathology laboratories, with installations across the country.

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.